from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0146/-

LFCtreatmentdescriptionclass of inhibitor

-0.775

Amikacinug/mL Amikacintranslation

-0.711

Cap5-10ug/mL Capreomycintranslation

-0.690

Rox10-50 ug/mL Roxithromycintranslation

0.782

SM2-5 ug/mL Streptomycintranslation

-1.990

Tet5-10 ug/mL Tetracyclinetranslation

0.066

Rif0.2-5ug/mL Rifampicintranscription

0.469

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.574

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.093

CPZ10-50 ug/mL Chlorpromazinerespiration

0.379

Clofazimine10-13 ug/mL Clofaziminerespiration

0.353

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.426

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.256

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.039

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.633

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.125

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.528

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.181

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.755

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.402

KCN5-20 ug/mL Potassium cyaniderespiration

0.849

NaN30.2-2 mM Sodium aziderespiration

-0.828

Nigericin50 uM Nigericinrespiration

-0.115

TRC10-150 ug/mL Triclosanrespiration

0.070

TRZ10-25 ug/mL Thioridazinerespiration

-1.194

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.867

menadione6-10 ug/mL Menadionerespiration

1.103

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.213

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.816

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.008

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.188

NRP_1Non-replicating persistence stage 1dosRassociated

-0.178

Amp0.2mg/mL AmpicillincellWall

-0.032

Cephalexin20-100 ug/mL CephalexincellWall

1.089

Cerulenin0.32-5 ug/mL CerulenincellWall

0.027

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.372

EMB10-20 ug/mL EthambutolcellWall

1.035

Eta12-40 ug/mL EthionamidecellWall

1.098

INH0.2-0.4 ug/mL IsoniazidcellWall

1.423

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.130

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.049

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.355

BZA0.12 mg/mL BenzamidearomaticAmides

-1.302

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.061

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.301

H2O24 mM hydrogen peroxideDNAdamaging

-0.186

Levo10 ug/mL LevofloxacinDNAdamaging

0.436

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.444

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.363

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.430

UVUV-irradiationDNAdamaging

-0.005

ARP41-4 ug/mL Antitubercular compound ARP4?

0.203

Antimycin12.5-50 ug/mL Antimycin A?

-0.418

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.186

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.147

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.642

PA8240.2-2 ug/mL PA-824?

0.030

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.039

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.285

Verapamil50 uM Verapamil?

-0.644

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.465

methoxatin10-20 ug/mL Methoxatin?